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The Bcl-2 regulated apoptosis pathway is critical for the elimination of autoreactive lymphocytes,
thereby precluding autoimmunity. T cells escaping this process can be kept in check by regulatory T
(Treg) cells expressing the transcription and lineage commitment factor Foxp3. Despite the well-
established role of Bcl-2 family proteins in shaping the immune system and their frequent deregula-
tion in autoimmune pathologies, it is poorly understood how these proteins affect Treg cell development
and function. Here we compared the relative expression of a panel of 40 apoptosis-associated genes in
Treg vs. conventional CD4þ T cells. Physiological signiﬁcance of key-changes was validated using gene-
modiﬁed mice lacking or overexpressing pro- or anti-apoptotic Bcl-2 family members. We deﬁne
a key role for the Bim/Bcl-2 axis in Treg cell development, homeostasis and function but exclude a role
for apoptosis induction in responder T cells as relevant suppression mechanism. Notably, only lack of the
pro-apoptotic BH3-only protein Bim or Bcl-2 overexpression led to accumulation of Treg cells while loss
of pro-apoptotic Bad, Bmf, Puma or Noxa had no effect. Remarkably, apoptosis resistant Treg cells showed
reduced suppressive capacity in a model of T cell-driven colitis, posing a caveat for the use of such long-
lived cells in possible therapeutic settings.
 2011 Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
Regulatory T (Treg) cell dependent suppression and apoptosis of
immune effector cells are both essential in establishing and main-
taining peripheral tolerance. Failure in either process can result in
an overshooting immune response and foster the development of
autoimmunity.
Two separate apoptosis signalling pathways contribute to
preclude autoimmunity. The extrinsic pathway is induced byeta; TCR, Tcell receptor; Bcl-2,
iator of cell death;MFI, mean
s; iTreg, induced regulatory T
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-NC-ND license.ligation of membrane-bound death receptors (DR; e.g. CD95 or
TRAIL-R) with their cognate ligands (CD95L or TRAIL), whereas the
intrinsic or mitochondrial pathway is triggered in response to
diverse forms of cell stress including cytokine-deprivation or high-
afﬁnity ligation of antigen receptors and mediated by proteins of
the Bcl-2 family [1]. The latter are divided according to function in
anti- and pro-apoptotic proteins. Anti-apoptotic proteins (e.g. Bcl-2,
Bcl-x or Mcl-1) contain up to four Bcl-2-homology domains (BH1-
4), pro-apoptotic Bax/Bak-like proteins three (BH1-3) and ‘BH3-
only’ proteins (e.g. Bim, Puma) only one, i.e. the BH3 domain.
Defective signalling along the extrinsic apoptosis pathway can
underlie the pathogenesis of autoimmune disease in mice and
humans as exempliﬁed by the loss of CD95-mediated apoptosis in
autoimmune prone lpr mice and patients suffering from autoim-
mune lymphoproliferative syndrome (ALPS) [2]. Also, deviations of
the intrinsic pathway contribute to the establishment of autoim-
munity. Loss of Bim or Bcl-2 overexpression in mice impairs nega-
tive selection of thymocytes and developing B cells expressing self-
reactive antigen receptors and Bim plus Puma co-regulate
lymphocyte homeostasis in the periphery [3]. Forced over-
expression of Bcl-2 orMcl-1 causes lymphadenopathy, can facilitate
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munity in mice [6,7]. Deletion of activated cells after antigenic
challenge is impaired in Bim-deﬁcient or Bcl-2 overexpressing
animals thereby facilitating the development of SLE-like pathology
[7,8]. Consistently, high-level expression of Bcl-2 or its pro-survival
homologues is frequently associated with different types of AID in
humans [9e11].
Treg cells are characterized by the expression of distinct cell
surfacemolecules including CD4, the IL-2Ra chain (CD25), GITR and
CTLA-4 but the transcription factor Foxp3 appears to be the only
reliable marker [12]. Treg cells arise naturally in the thymus (nTreg)
or can be induced (iTreg) in the periphery from CD4þFoxp3 naïve
T cells in response to TGF-b plus IL-2 or retinoic acid [13]. Their
immune suppressive capacity involves the secretion of anti-
inﬂammatory cytokines (e.g. TGF-b, IL-10), cell-to-cell contact
dependent mechanisms (e.g. CTLA-4) or active transfer of small
immune-modulatory metabolites such as cAMP [14,15]. Previous
reports also suggested that induction of apoptosis in activated
T cells, e.g. due to expression of DR ligands such as TRAIL [16] or
CD95L [17] on Treg cells, or Treg-dependent IL-2 deprivation of
activated T cells [18], triggering Bcl-2 regulated cell death, may
contribute.
Loss of Foxp3 triggers the scurfy phenotype in mice and immune
dysregulation, polyendocrinopathy, enteropathy, and X-linked
inheritance (IPEX) in humans [19,20]. Importantly, the timed
deletion of Treg cells in adult mice results in scurfy-like pathology
[21]. Moreover, Treg number and function are frequently reduced in
patients suffering from autoimmunity [22,23]. These ﬁndings
demonstrate the importance and simultaneously highlighting the
therapeutic potential of Treg cells for the treatment of autoimmu-
nity or other pathologies such as graft vs. host disease.
Despite the well-established role of Bcl-2 family proteins in
lymphocyte development and homeostasis, only fragmented
information is available concerning their impact on Treg cell
biology. To gain insight, we investigated the relative expression
levels of Bcl-2 family proteins in Treg cells derived from thymus or
spleen in relation to that found in developing thymocytes or
conventional CD4þ T cells. In addition, we explored the impact of
loss- or gain-of-function of key Bcl-2 family proteins on Treg cell
development, their cell death responsiveness as well as their
suppressor function in vitro and in vivo.
2. Materials and methods
2.1. Mice
C57BL/6 foxp3gfp reporter mice [24] were purchased from Jack-
son Laboratories, backcrossed 3 more generations to C57BL/6 (total
8 times) and crossed with congenic Bim/ [8], vav-Bcl-2 [25] mice
to obtain foxp3gfpBim/ and foxp3gfpvav-Bcl-2 mice. RAG1/ mice
were a kind gift from A. Moschen, Department of Internal Medicine
II. The generation of mice deﬁcient for Bad [26], Bmf [27], Puma [28]
or Noxa [28] has been described. All animals used in this studywere
on a C57BL/6 background and 6e12 weeks of age. All animal
experiments were performed in accordance with the Austrian
“Tierversuchsgesetz” (BGBl. Nr. 501/1988 i.d.F. 162/2005) and have
been granted by the Bundesministerium für Bildung, Wissenschaft
und Kultur (BMWF-66.011/0167-II/3b/2011).
2.2. Cell sorting
To obtain CD4þFoxp3-GFP conventional Tcells and CD4þFoxp3-
GFPþ natural Treg cells single cell suspensions were prepared from
splenocytes and thymocytes isolated from foxp3gfp wild type,
foxp3gfpBim/, foxp3gfpvav-Bcl-2 mice and stained withﬂuorochrome-labelled antibodies recognizing mouse CD4 and
7AAD to exclude dead cells. Cell sorting was performed using
a FACSVantage cell sorter (Becton Dickinson). Purity of isolated cell
populations was routinely 98%.
2.3. Flow cytometry
The followingﬂuorochrome-labelledantibodiesor reagentswere
used for extra- and intracellular staining: rat anti-mouse CD4 mAb
(L3T4), rabbit anti-mouse GITR (YGITR 765, Biolegend), rat anti-
mouse Foxp3 (FJK-16s) from eBioscience; 7AAD from Sigmae
Aldrich; rat anti-mouse CD25 mAb (3C7), hamster anti-mouse
CTLA-4 mAb (UC10-4B9) and AnnexinV-Alexa647, rat anti-mouse
IFN-g (XMG1.2), rat anti-mouse IL-17A mAb (TC11-18H10.1) from
Biolegend.
For intracellular staining of cytokines cells were stimulated with
50 ng/ml PMA (Fluka Biochemika) and 1 mg/ml Ionomycin (Sigma)
for 5 h. During the last 3 h of cell culture Monensin (Biolegend) was
added. Then cells were ﬁxedwith ﬁxation buffer and permeabilized
with permeabilization buffer (Biolegend) according to the manu-
facturer’s instructions. For intracellular Foxp3 staining, buffers
were purchased from eBioscience. Flow cytometry measurements
were performed using a FACSCalibur (BD Biosciences) and analyzed
by Cellquest (BD Biosciences) or WinMDI.
2.4. Apoptosis assays
To asses apoptosis susceptibility cells were cultured in media
(supplemented with 10% FCS,100 U/ml Pen/Strep, 2 mM glutamine,
1 mM pyruvate, 1 non-essential amino acids, 50 mM beta-
mercaptoethanol) in the presence or absence of 100 U/ml IL-2
(Peprotech), 20 ng/ml IL-7 (Peprotech), 108 M Dexamethasone
(SigmaeAldrich), 10 mg/ml Etoposide (SigmaeAldrich), 1 mM SAHA
(a gift from R. Johnstone, Peter MacCallum Cancer Center, Mel-
bourne, Australia), 100 nM Staurosporine (SigmaeAldrich). To
induce apoptosis by Fas ligation, cells were cultured in the presence
of human 100 ng/ml FasL (Alexis Biochemicals) and crosslinked
with 1 mg/ml anti-FLAG (M2, SigmaeAldrich). The percentage of
living cells was assessed by AnnexinV/7AAD staining. Increased and
relative survival was calculated by normalisation to medium
cultured cells.
2.5. T cell suppression assay
Freshly puriﬁed CD4þFoxp3-GFPþ nTreg cells were tested
functionally in a co-culture suppression assay. Triplicates of
different nTreg cell ratios were co-cultured with 5104/ml splenic
CD4þFoxp3-GFP responder T cells, 2105/ml APCs (irradiated
total splenocytes, 30 Gy) and 0.5 mg/ml anti-CD3 (2C11) in 96-well
U-bottom plates for 72 h. 1 mCi [3H]-thymidine/well was added for
the last 16 h. Cells were transferred onto glass ﬁber ﬁlters using
a Combi-cell-harvester (Molecular Devices) and proliferation
measured by scintillation counting in a beta-Counter (Beckman
Coulter).
2.6. RNA isolation and quantitative RT-PCR
RNA isolation (Zymo research) and cDNA synthesis (Biorad)
were performed according to the manufacturer’s instructions. Real
time PCR was done using the following primers (50e30): A1
CCTGGCTGAGCACTACCTTC (sense) and TCCACGTGAAAGTCATCCAA
(antisense); b-actin ACTGGGACGACATGGAGAAG (sense) and
GGGGTGTTGAAGGTCTCAAA (antisense); Bcl-2, CTGGCATCTTCTCC
TTCCAG (sense) and GACGGTAGCGACGAGAGAAG (antisense); Bcl-
xL TTCGGGATGGAGTAAACTGG (sense) and TGGATCCAAGGCTCT
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TCAGCCTCGCGGTAATCATT (antisense); Mcl-1 TAACAAACTGGGGCA
GGATT (sense) and GTCCCGTTTCGTCCTTACAA (antisense); Noxa
CCCACTCCTGGGAAAGTACA (sense) and AATCCCTTCAGCCCTTGATT
(antisense); Puma CAAGAAGAGCAGCATCGACA (sense) and
TAGTTGGGCTCCATTTCTGG (antisense). Quantitative RT-PCR was
performed using a Mastercycler Gradient (Eppendorf) and the
DyNAmo Flash SYBR mastermix (Finnzymes) according to the
manufacturer’s instruction. The results were normalized to b-actin
expression and evaluated using the DDCT relative quantiﬁcation
method.
2.7. Multiplex ligation-dependent probe ampliﬁcation (RT-MLPA)
RNA amounts were analyzed with the Apoptosis Mouse RT-
MLPA kit RM002 (MRC-Holland, http://www.mlpa.com) according
to the manufacturer’s instructions [29]. Samples were run through
a Genescan and analyzed with Gene-Mapper (Applied Biosystems
GmbH; http://www.appliedbiosystems.com) and subsequently
using the Statview software program (Abacus).
2.8. T cell transfer model of colitis
CD4þFoxp3-GFP conventional T cells were isolated from con-
genic C57BL/6 foxp3gfp mice and injected i.p. into 6e10-week-old
C57BL/6 RAG1/ immunodeﬁcient recipients (4105 cells/
mouse). 1105 wild type or vav-Bcl-2 CD4þFoxp3-GFPþ Treg cells
were co-injected i.p. where indicated. Mice were monitored every
3e4 days for wasting disease. Mice were sacriﬁced either losing
>25% of its initial body weight or 7 weeks after cell transfer.
2.9. Histological assessment of intestinal inﬂammation
Samples of proximal colon, mid-colon, and distal colon were
ﬁxed in buffered 4% formalin solution. 3 mm parafﬁn-embedded
sections were cut and stained with hematoxylin and eosin.
Tissues were graded semi-quantitatively from grade 0 to 4 in
a blinded fashion. Grade 0: no changes observed, grade 1: discrete
increased inﬂammatory cells in the lamina propria with gran-
ulocytes in the lamina epithelialis, grade 2: as grade 1 with scat-
tered erosions of the mucosa, grade 3: increased inﬂammatory cells
in the lamina propria and scattered crypt abscesses, grade 4: all
signs of grade 3 plus more than 3 crypt abscesses per colon
circumference in the scanning magniﬁcation (40).
2.10. Statistics
Estimation of statistical differences between groups was carried
out using the unpaired Student’s t-test or Mann Whitney U test,
where appropriate. P-values of  0.05 were considered to indicate
statistically signiﬁcant differences.
3. Results
3.1. Distinct expression patterns of anti- and pro-apoptotic Bcl-2
family members are found in nTreg vs. conventional T cells
First we investigated if Treg and conventional CD4þ T cells
(Tcon) differ in their repertoire of 40 apoptosis-associated genes,
including all pro- and anti-apoptotic Bcl-2 family members.
Therefore, Treg cells, CD4þ8 thymocytes or CD4þ Tcon cells were
isolated from the thymus or spleen of foxp3gfp reporter mice based
on cell surface marker and GFP expression by cell sorting. RNA was
isolated and analyzed by RT-MLPA (Suppl. Table 1) and quantitative
(q)RT-PCR (Fig. 1A). In the thymus, Treg cells expressed highermRNA levels encoding anti-apoptotic Mcl-1, Bcl-xL or A1/Bﬂ-1,
when compared to CD4þ8 thymocytes. In contrast, expression of
pro-apoptotic Bimwas found reduced in Treg cells while mRNA for
Puma was more and that for Noxa seemed most abundant in this
relative comparison (Fig. 1A).
In contrast, in the spleen only mRNAs for Bcl-xL, A1/Bﬂ-1 and
Noxa were found to be overrepresented in Treg cells, whereas no
difference was observed for transcripts encoding Bcl-2, Mcl-1, Bim
or Puma, suggesting that Bcl-xL levels may deﬁne increased cell
death thresholds in nTreg cells in the periphery. All other cell death
related genes ampliﬁed in the RT-MLPA analysis were either not
expressed or found comparable in their levels with one notable
exception, BIRC1A/NAIP, a member of the NOD-like receptor family,
initially implicated as an apoptosis inhibitor in neurons, that was
signiﬁcantly more abundant in Treg cells derived from thymus or
spleen (Suppl. Table 1).
Next we investigated if loss of BH3-only protein function or Bcl-
2 overexpression had an impact on nTreg cell homeostasis in vivo.
Therefore, we quantiﬁed the percentage and number of
CD4þFoxp3þTreg cells in the thymus and spleens of mice lacking
the BH3-only proteins Bim, Bmf, Bad, Puma or Noxa and compared
it to the consequences of transgenic overexpression of Bcl-2. This
analysis revealed a relative increase in the percentage of nTreg cells
in Bim-deﬁcient or vav-Bcl-2 transgenic mice (Fig. 1B). No differ-
ences in Treg cell number were observed in all other knockout
animals analyzed (Fig. 1C), including those lacking Puma or Noxa,
despite the higher mRNA levels observed in wild type Treg cells
(Fig. 1A).3.2. nTreg cells differ in their cell death responsiveness from
conventional T cells
Based on our ﬁndings related to gene expression and the
observed accumulation of Treg cells in Bim-deﬁcient or Bcl-2
overexpressing mice, we assessed if Treg cells differ from CD4þ8
thymocytes or CD4þ Tcon cells from spleen in their susceptibility to
apoptosis. Therefore, CD4þFoxp3-GFPþ Treg cells, CD4þ8Foxp3-
GFP thymocytes or CD4þFoxp3-GFP Tcon cells were isolated
from the thymus or spleen of mice from the different genotypes.
Cells were exposed to a broad range of apoptotic stimuli triggering
Bcl-2 dependent apoptosis, including cytokine deprivation, treat-
ment with the glucocorticoid dexamethasone, the DNA-damaging
drug etoposide, the histone-deacetylase (HDAC)-inhibitor SAHA,
the broad-spectrum kinase-inhibitor staurosporine and, for refer-
ence, CD95 ligation. Compared to CD4þ8 thymocytes (Suppl. Fig.1)
or splenic Tcon cells (Fig. 2), Treg cells died more rapidly in the
absence of cytokines and were efﬁciently rescued by addition of IL-
2, in line with their strict dependence on this cytokine for survival
[30], but also by the addition of IL-7. Consistently, loss of Bim aswell
as Bcl-2 overexpression protected them from spontaneous death in
culture (Fig. 2AeC). Next to cytokine deprivation, Treg cells were
found more susceptible to apoptosis induced by the HDAC inhibitor
SAHA, and Fas ligation (Fig. 2D, E). Loss of Bim or Bcl-2 over-
expression protected Treg cells from SAHA but not CD95-induced
apoptosis. In contrast, Treg cells were more resistant to apoptosis
induced by the glucocorticoid dexamethasone, etoposide or staur-
osporine when compared with Tcon cells (Fig. 2FeH). This differ-
encemight be explained with increased level of Bcl-xL in these cells
(Fig. 1), whereas in the thymus, Treg cells displayed increased
survival only in response to staurosporine treatment. As in Tcon
cells, absence of Bim or Bcl-2 overexpression conferred partial or
complete protection to dexamethasone or staurosporine while
etoposide killing was only blocked by Bcl-2 overexpression (Fig. 2;
Suppl. Fig. 1).
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Fig. 1. Differential expression of proteins of the Bcl-2 family by Treg cells in the thymus and spleen. CD4þFoxp3-GFPþ Treg, CD4þ8Foxp3-GFP thymocytes, or CD4þFoxp3-GFP
Tcon cells were isolated from the (A) thymus or spleen, respectively. Relative mRNA expression of Bcl-2 family members was analyzed by quantitative RT-PCR. Expression in
CD4þFoxp3-GFP Tcon cells was set to 1. Bars represent means SEM of n¼ 5 independent samples. (B) Relative abundance of CD4þFoxp3-GFPþ Treg cells among CD4þ T cells in
the thymi and spleens of foxp3gfpwt (n¼ 8), foxp3gfpBim/ (n¼ 3) and foxp3gfpvav-Bcl-2 (n¼ 5) mice. (C) Abundance of CD4þFoxp3-GFPþ Treg cells among CD4þ T cells in the thymi
and spleens of wt (n 8), Bmf/ (n 4), Puma/ (n 5), Noxa/ (n¼ 2) and Bad/ (n¼ 2) mice. Bars represent means SEM; statistics: Student’s t-test and MannWhitney U test
for Noxa in the spleen. *p 0.05, **p 0.01, ***p 0.001.
D. Tischner et al. / Journal of Autoimmunity 38 (2012) 59e6962Collectively, our ﬁndings show that although cell death sig-
nalling pathways and responses are generally conserved between
Tcon and Treg cells, differences in relative sensitivity to certain
forms of stress do exist, that correlate with the different expres-
sion patterns of certain Bcl-2 family proteins described above
(Fig. 1).3.3. Reduced expression of Treg cell markers due to loss of Bim or
Bcl-2 overexpression
Because apoptosis differently affected Treg and Tcon cells we
wanted to know if and how deregulation of cell death impacts on
Treg cell phenotype and function. Therefore,we analyzedexpression
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Fig. 2. Splenic Treg and Tcon cells display different susceptibility to mitochondrial apoptosis. Wild type, Bim/ and vav-Bcl-2 CD4þFoxp3-GFPþ Treg and CD4þFoxp3-GFP Tcon
cells were puriﬁed from the spleen and survival analyzed by AnnexinV/7AAD staining. Only AnnexinV/7AAD negative cells were considered alive. Cells were cultured either (A) in
medium for 9, 18 and 48 h or in the presence of (B) 100 U/ml IL-2, (C) 20 ng/ml IL-7, (D) 1 mM SAHA, (E) 100 ng/ml FasL, (F) 108 M Dexamethasone, (G) 10 mg/ml Etoposide and (H)
100 nM Staurosporine for 18 h. For calculation of increased and relative survival cell viability was normalized to medium values. Symbols and bars represent means SEM of
n¼ 3e10 data points acquired in 3 independent experiments; statistics: Student’s t-test *p 0.05, **p 0.01, ***p 0.001 Treg cells were compared to Tcon cells; þþp 0.01,
þþþp 0.001 wild type Treg and Tcon cells, respectively were compared to their Bim/ and vav-Bcl-2 counterparts.
D. Tischner et al. / Journal of Autoimmunity 38 (2012) 59e69 63of Treg cell markers in foxp3gfpwild type, foxp3gfpBim/ and
foxp3gfpvav-Bcl-2 mice, the latter two showing increased Treg cell
numbers. While in wild type mice nearly all Foxp3-GFPþ cells were
CD4þ (Fig. 3A, B), we observed an increased number of CD8þFoxp3-
GFPþ cells in the spleens of foxp3gfpBim/ and foxp3gfpvav-Bcl-2
mice. Surprisingly, up to 40% of Bim/ and vav-Bcl-2 Foxp3-GFPþ
cells in the thymus lacked CD4 or CD8 expression and evenmigrated
to the periphery (Fig. 3A, B). Furthermore, expression of typical Treg
cell markers, such as Foxp3, CD25 and GITR were diminished
in Bim/ mice, an effect even more pronounced, in vav-Bcl-2 Treg
cells (Fig. 3CeF and Suppl. Fig. 2). CTLA-4 expression, required for
Treg cell effector function, was signiﬁcantly reduced in thymic
Bim/ and vav-Bcl-2 Treg cells but this phenomenonwas no longer
seen in the spleen. Overall, Treg cell marker reduction was more
pronounced in the thymus than the spleen. Together this indicates,
that defective cell death signalling impacts on the maturation
programof Treg cells thatmay also impact on their effector function.
3.4. Treg cells derived from foxp3gfpBim/ or foxp3gfpvav-Bcl-2
mice show impaired suppressive capacity
Expression levels of Foxp3 inTreg cells highly correlatewith their
suppressive capacity and forced expression of Foxp3 in formerFoxp3CD4þ Tcells confers suppressive function [31]. Because Foxp3
amounts were reduced in foxp3gfpBim/ and foxp3gfpvav-Bcl-2 Treg
cells we assessed if their suppressive potential might be impaired in
an in vitro suppression assay system. Therefore, CD4þFoxp3-GFP
Tcon cells were stimulated either alone or in the presence of geno-
type matched Treg cells. Treg cells from all genotypes were able to
suppress their matching Tcon cells but while suppression of wild
type or Bim/ Tcon cells seemed similar, that of vav-Bcl-2 Tcon cells
was clearly less efﬁcient (Fig. 4A). This marked difference may be
related to changes in function or responsiveness of nTreg and/or Tcon
cells overexpressing Bcl-2 that may include increased survival
(Fig. 2) and/or inferior proliferative capacity (not shown).
It has been proposed that responder T cells can differ in their
susceptibility to Treg cell mediated suppression when cell death is
impaired [18]. Thus, we cultured wild type, Bim-deﬁcient or vav-
Bcl-2 transgenic Tcon cells together with wild type Treg cells and
assessed their proliferation capacity. Proliferation of Bim/ and
vav-Bcl-2 Tcon cells was efﬁciently suppressed in the presence of
wild type Treg cells (Fig. 4B). Surprisingly, suppression of Bim/
Tcon cells by wild type Treg cells was even more efﬁcient than that
of wild type or vav-Bcl-2 Tcon cells when limiting dilution experi-
ments were performed. While the reasons for the increased
susceptibility of Bim-deﬁcient CD4þ T cells over those expressing
Fig. 3. Treg cell marker expression is reduced in Bim/ and vav-Bcl-2 Treg cells. (A) Representative dot-plot analysis of CD4 and CD8 cell surface marker expression by Foxp3-GFPþ
Treg cells in the thymus (left column) or spleen (right column) of wild type, Bim/ or vav-Bcl-2mice. (B) Quantiﬁcation of CD4 and CD8 distribution among of Foxp3-GFPþ Treg cells
in the thymus (upper panel) or spleen (lower panel). Bars represent means SEM of wt n¼ 11; Bim/ n¼ 6; vav-Bcl-2 n¼ 5 animals. (C) Representative dot-plot analysis of CD25
expression on the cell surface of wild type, Bim/ and vav-Bcl-2 Treg cells in the thymus (left column) or spleen (right column). (D) Quantiﬁcation of CD25 expression as in (B).
Mean ﬂuorescence intensity (MFI) of Foxp3-GFP, GITR and CTLA-4 by CD4þFoxp3-GFPþ Treg cells in the (E) thymus or (F) spleen (wt n 9; Bim/ n 3; vav-Bcl-2 n 3); bars
represent means SEM of 3 independent experiments; statistics: Student’s t-test *p 0.05, **p 0.01, ***p 0.001.
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strate that induction of apoptosis in Tcon cells does not play
a signiﬁcant role in suppression, as most recently also noted by
Vignali et al. [32].
Keeping in mind that Bim-deﬁcient T cells were reported to be
more anergic and to respond more reluctantly to antigenic chal-
lenge [33], we reasoned that differences in Treg cell function may
become distinguishable when apoptosis-defective Treg cells
needed to suppress functionally fully competent responder T cells.
In line with this hypothesis, when wild type Tcon cells were incu-
bated with Bim/ or vav-Bcl-2 Treg cells a clear-cut difference was
observed, as both genotypes were less effective in suppressing wild
type Tcon cells, when compared to controls (Fig. 4C). The
suppressive capacity of vav-Bcl-2 Treg cells was weakest and this
phenotype correlated with lower levels of Foxp3 in these cells,
a phenomenon also noted in Bim/ Treg cells, albeit less
pronounced (Fig. 3). To assess if Foxp3 expression directly impacts
on Treg cell function we divided vav-Bcl-2 Treg cells in Foxp3-
GFPhigh and Foxp3-GFPlow groups and compared their suppressive
potential with that of unseparated (Foxp3-GFPall) and wild type
Treg cells that all showed high levels of GFP expression (Foxp3-
GFPhigh) (Fig. 4C). Indeed, Foxp3-GFPlow vav-Bcl-2 Tregs were
weaker in the suppression of Tcon cells compared to all other Treg
subpopulations. Surprisingly, Foxp3-GFPhigh vav-Bcl-2 Treg cells
were still less potent when compared to wild type Foxp3-GFPhigh
Treg cells (Fig. 4D), indicating that the levels of Foxp3 in these cells
do not deﬁne suppressive capacity alone. Impaired function
becomes best apparent when apoptosis-defective Treg cells are
challenged with fully competent CD4þ responder T cells. Hence
deregulation of Bcl-2 family protein levels in Treg cells may
contribute to inﬂammatory phenotypes frequently underlying
autoimmunity.Fig. 4. Bim/ and vav-Bcl-2 Treg cells display reduced suppressive capacity in vitro. Diff
stimulated with anti-CD3 mAb (2C11) for 3 days. T cell proliferation was assessed by [H3]
normalized to Tcon cell proliferation in the absence of Treg cells. (A) Proliferation of wild ty
Treg cells with the same genotype. (B) Proliferation of wild type (n¼ 19), Bim/ (n¼ 7) or v
type Tcon cells were used as responder T cells and cultured with or without wild type (n¼ 19
with wt Foxp3-GFPhigh (n¼ 4), unseparated vav-Bcl-2 (Foxp3-GFPall) (n¼ 4) Tregs or vav-Bc
points represent means SEM; statistics: Student’s t-test *p 0.05, **p 0.01, ***p 0.001.3.5. Bcl-2 transgenic Treg cells fail to effectively suppress
inﬂammatory bowel disease
To evaluate if vav-Bcl-2 derived Treg cells also display an
impaired suppressive function in vivo we tested their capacity to
prevent T cell induced colitis. Therefore, 4105 CD4þFoxp3-GFP
wild type conventional T cells were transferred alone (control
group) or together with 1105 CD4þFoxp3-GFPþ wild type or vav-
Bcl-2 Treg cells into RAG1/mice. Animals receiving only Tcon cells
without Treg cells rapidly developed colitis, indicated by strong
weight loss and had to be sacriﬁced early on, displaying a colitis
score of 3, according to histopathological assessment (Fig. 5A; not
shown). Transfer of wild type Treg cells successfully prevented
development of colitis during the whole observation period
whereas mice receiving vav-Bcl-2 Treg cells succumbed to disease,
initially even as quickly as mice that only received conventional
CD4þ T cells (Fig. 5A). However, after two weeks their weight loss
decelerated, suggesting at least a partial suppression of disease by
vav-Bcl-2 Treg cells but animals never fully recovered during the
whole observation period (Fig. 5AeC). Animals were sacriﬁced after
7 weeks. Consistent with a pro-inﬂammatory phenotype, total
splenic cellularity was signiﬁcantly increased in animals that
received vav-Bcl-2 Treg cells compared to wild type controls due to
an increase in Mac-1þ cells (not shown), while the number of
conventional CD4þ T and Treg cells remained comparable (Suppl.
Fig. 3A). Notably, signiﬁcantly more IFN-g producing CD4þ Tcon
cells were found in the mesenteric lymph nodes of mice treated
with Treg cells overexpressing Bcl-2 than mice that received wild
type cells while no difference was observed in IL-17 production
(Fig. 5E, F). Mesenteric lymph node cellularity (Fig. 5D) and IFN-g or
IL-17 secretion in spleen were indistinguishable between the
groups (Suppl. Fig. 3B). Together, these ﬁndings strongly supporterent ratios of splenic CD4þFoxp3-GFPþ Treg and CD4þFoxp3-GFP Tcon cells were
-thymidine incorporation added during the last 16 h of cell culture. Proliferation was
pe (n¼ 19), Bim/ (n¼ 6) or vav-Bcl-2 (n¼ 9) Tcon cells in the absence or presence of
av-Bcl-2 (n¼ 9) Tcon cells cultured in the absence or presence of wt Treg cells. (C) Wild
), Bim/ (n 6) or vav-Bcl-2 (n¼ 9) Treg cells. (D) wt Tcon cells were cultured alone or
l-2 Tregs divided into Foxp3-GFPhigh (n¼ 3) and Foxp3-GFPlow Tregs cells (n¼ 4). Data
Fig. 5. vav-Bcl-2 Treg cells fail to effectively prevent induction of colitis. Colitis was induced in RAG1/ mice by adoptive transfer of 4105 wild type CD4þFoxp3-GFP Tcon cells
without (control group; n¼ 3) or together with 1105 wild type (n¼ 4) or vav-Bcl-2 CD4þFoxp3-GFPþ Treg cells (n¼ 4). Animals were sacriﬁced when weight loss reached >25%
(control group) or on day 46 after cell transfer (mice receiving either wild type or vav-Bcl-2 Treg cells). (A) Depicted is the relative weight change normalized to the starting weight
before cell transfer. (B) Representative H&E stained mid-colon sections and (C) colitis score of mice treated with wild type Tcon cells, either together with wild type or vav-Bcl-2
CD4þFoxp3-GFPþ Treg cells. (D) Absolute cell number (left panel), Tcon (middle panel) and Treg cell number (right panel) in the mesenteric lymph nodes of mice receiving wild type
Tcon cells either together with wild type (wt) or vav-Bcl-2 (Bcl-2) Treg cells. Expression of (E) IFN-g and (F) IL-17A by CD4þFoxp3-GFP Tcon cells in the mesenteric lymph node after
5 h stimulation in vitro in the presence of PMA/Ionomycin has been analyzed by intracellular staining and ﬂow cytometry. Data points represent means SEM; one out of two
independent experiments is shown; statistics: Student’s t-test *p 0.05, **p 0.01.
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D. Tischner et al. / Journal of Autoimmunity 38 (2012) 59e69 67the pathophysiological relevance of deregulated mitochondrial cell
death signalling in Treg cell function, warranting a more detailed
analysis of Bcl-2 family protein expression in Treg cells from
patients with autoimmune disease.
3.6. Inﬂammation can restore the suppressive capacity of Bcl-2
overexpressing Treg cells
To assess which impact the ongoing inﬂammatory response had
in relation to the delayed recovery of mice that received Bcl-2
transgenic Treg cells, we also compared expression of Foxp3-GFP,
CD25, GITR and CTLA-4 in wild type and vav-Bcl-2 Treg cells before
and after transfer. Treg cells in the spleen of vav-Bcl-2 mice dis-
played signiﬁcantly reduced levels of Foxp3-GFP, CD25 and GITR
(Fig. 3), but surprisingly the opposite phenotype was observed 7
weeks after disease induction (Fig. 6A, B). While GITR was now
comparable between wild type and vav-Bcl-2 Treg cells (Suppl.
Fig. 4D, E), Foxp3 as well as CD25 expression were even signiﬁ-
cantly higher in vav-Bcl-2 Treg cells (Fig. 6A, B and Suppl. Fig. 4A, B).
In addition, when these cells were tested in an in vitro suppression
assay, wild type and vav-Bcl-2 Treg both efﬁciently suppressed wt
Tcon cells (Suppl. Fig. 4F). This indicates that reduced Treg cell
lineage marker expression and suppression capacity by vav-Bcl-2
Treg cells do not result from a cell intrinsic developmental defect as
these deﬁciencies can be overcome under pro-inﬂammatory
conditions. Notably here, as in vav-Bcl-2 mice, we also observed
the emergence of CD4Foxp3-GFPþ vav-Bcl-2 Treg cells after
transfer into RAG1/mice (Fig. 6C and Suppl. Fig. 4C). This suggests
that defective cell death signalling allows their undesired survival
after exhaustion that associates with phenotypic changes.
4. Discussion
In this study, we assessed how Bcl-2 regulated apoptosis
impacts on Treg cell apoptosis susceptibility, maturation, pheno-
type and functionality. Our RT-MLPA expression analysis demon-
strates that Treg cells differ from Tcon cells in their repertoire of
pro- and anti-apoptotic proteins expressed that contribute towt
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stimuli (Figs. 1 and 2). Proteins of the Bcl-2 family are critically
involved in T cell selection andmaturation processes in the thymus.
For example Mcl-1 and A1 are induced upon cytokine and (pre)TCR
signalling in immature double negative thymocytes [34,35] and
Bcl-xL becomes the major survival protein in double-positive
thymocytes where Bcl-2 levels become repressed [36] and Bim
executes negative selection [37]. Contrary to conventional CD4þ T
cells, Treg cells require a stronger TCR signal for development in the
thymus and are more resistant to negative selection compared to
conventional CD4þ Tcells [38,39]. This idea is also supported by our
results. Levels of Bcl-xL were found higher and those for Bim were
reduced, circumventing negative selection. Higher Mcl-1 and A1
levels may result from strong TCR signalling received during
negative selection and may be required to antagonize the simul-
taneous increase in Noxa levels observed in these cells (Fig. 1).
In the periphery Treg cells also differ from Tcon cells in
expression levels of proteins of the Bcl-2 family. Most notably, Bcl-
xL that is usually downregulated in mature T cells and replaced by
Bcl-2 [36] was found increased, indicating either stimulation by
self-peptide ligands in the periphery and/or cytokine stimulation
by IL-2 via constitutive expression of CD25 on Treg cells. These
differences may also account for the observed increased survival of
splenic Treg cells in response to dexamethasone, etoposide or
staurosporine. At least for the observed glucocorticoid resistance
a former study correlated augmented Bcl-2 levels and IL-2 with
survival advantages in Treg cells in response to dexamethasone
treatment [40]. In general, loss of pro-apoptotic Bim or over-
expression of anti-apoptotic Bcl-2 increased survival of both Treg
and Tcon cells alike, indicating conserved function of the Bcl-2
proteins family in both cell types.
Next to the increased survival capacity in response to the
aforementioned stimuli Tregs were more susceptible to cytokine
deprivation, HDAC-inhibition and Fas ligation. As Treg cells cannot
produce IL-2 [30] or IL-7 [41] they are highly susceptible to cytokine
deprivation. Thus, either loss of Bim or Bcl-2 overexpression, as
well as addition of common g-chain cytokines IL-2 or IL-7, rescued
Treg cells from apoptosis (Fig. 2). Former studies reported thatl-2 wt
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acetylation of Foxp3 increased its binding to the IL-2 promoter
thereby suppressing cytokine production [42]. However, HDAC-
inhibition can also lead to the induction of Bim in lymphoid
tumor cells [43] and, as shown here, ultimately triggers apoptosis
also in Treg cells. As noted before, Treg cells were found highly
susceptible to apoptosis induction by Fas ligation that may be due
to higher Fas surface expression by Treg cells compared toTcon cells
(Ref. [44] and Tischner et al., pers. observation). Notably, expression
of Noxa mRNA was found also to be much higher in splenic Treg
cells, as opposed to Tcon cells. Since Noxa expression can be
induced by antigenic stimulation in peripheral CD8þ Tcells [45], we
assume that stimulation by self-peptide/MHC molecules may
contribute to this phenotype but protein levels achieved appear
insufﬁcient to cause death. However, increased Noxa may prime
Treg cells to apoptosis, e.g. as it does conventional T cells under
glucose limiting conditions [46].
Similar to observations made with conventional T cells [8], Treg
cell number was augmented in Bim/ and vav-Bcl-2mice. Notably,
some of these cells developed into double negative Treg cells in the
thymus that were then also found in the periphery (Fig. 3). Cells in
the thymus seem to derive from SP4þ Treg cells, as they also stain
positive for the TCR-beta chain on their surface (not shown) and
presumably escaped negative selection. These observations are in
linewithmost recent ﬁndings by Zhan et al. who provided evidence
that these cells are actually autoreactive cells that have been
reprogrammed/redirected to commit to an anergic regulatory T cell
fate [47].
Notably, Bim/ and vav-Bcl-2 Treg cells showed reduced
expression of Foxp3, CD25, GITR and CTLA-4, the latter only in the
thymus (Fig. 3), suggesting that these cells may not be fully func-
tional whichwas conﬁrmed in vitro (Fig. 4) and in vivo (Fig. 5).While
we, and others [32], failed to note substantial differences in geno-
type matched suppression assays, arguing against the cytokine
consumption hypothesis for Tcell suppression [18], we also realized
that Bim/ and vav-Bcl-2 Treg cells displayed a reduced suppres-
sive capacity towards Tcon cells from wild type mice (Fig. 4).
However, attempts to deﬁne differences in calcium signalling,
known to be modulated by Bcl-2 [48], in Treg cells were unsuc-
cessful, questioning an intrinsic defect. Yet, vav-Bcl-2 Treg cells
showed also a strongly impaired suppressive capacity in vivo
(Fig. 5). However, isolated colitogenic vav-Bcl-2 transgenic Treg
cells from these mice showed even higher levels of CD25 and Foxp3
expression, when compared to wild type cells (Fig. 6) and were
equally potent in suppressing Tcon cells in vitro (Suppl. Fig. 4C). As
this phenomenon coincided with increased total splenocyte
number and IFN-g production by Tcon cells in themesenteric lymph
nodes (Fig. 5), we assume that the reduced suppressive capacity of
Treg cells in vav-Bcl-2mice is not cell intrinsic and can be overcome
during inﬂammation. Consistently, addition of IL-2 in vitro was
shown to increase Foxp3 expression in Bim-deﬁcient Treg cells [47],
in line with IL-2 signalling impacting directly on Foxp3 promoter
activity [49]. However, as mice never fully recovered their initial
body weight over a period of 7 weeks, we assume that Bcl-2
transgenic Treg cells may be able to recover only transiently or
carry additional defects that affect the biological outcome (Fig. 5).
Another open question is why these “disabled” Treg cells
develop in Bim/ and vav-Bcl-2 mice in the ﬁrst place and where
they originate. Zhan and colleagues propose that these cells accu-
mulate in such large number because they represent survivors of
negative selection deviated into an anergic Treg cell fate when
mitochondrial cell death is impaired. Consistently, these cells more
frequently expressed self-reactive TCRs against endogenous
superantigens and display low level CD25 expression, presumably
as they do no longer depend strictly on IL-2 for survival [47].However, our study shows that additional Treg cells lacking CD4
expression do accumulate in the thymus (Fig. 3C) and that these
cells can also arise de novo from CD4þ Treg cells during suppression
of T cell expansion in vivo (Fig. 6). We assume that these cells also
represent a pool of cells that should have been deleted, either in the
thymus during negative selection, or towards the end of an immune
response in the periphery. Whether these cells are still functional
remains to be determined.
5. Conclusions
Collectively, our ﬁndings demonstrate that cell death along the
intrinsic Bcl-2 regulated apoptosis pathway is critical for normal
development and function of Treg cells. Intrinsic differences in Bcl-
2 family protein expression impinge on the relative cell death
susceptibility of Treg cells to a number of stress signals that may
become of pathophysiological importance, such as those elicited by
glucocorticoids or cytokine withdrawal. Deregulated expression of
key effectors of the Bcl-2 family impairs lineage commitment and
suppressive capacity but these defects are not imprinted and
appear largely reversible during conditions of inﬂammation.
Therefore, attempts to increase the yield or lifespan of Treg cells
prior therapeutic application bymodulation of cell death regulators
should be feasible without signiﬁcantly compromising their regu-
latory capacity, albeit a certain caveat remains, warranting further
detailed investigations.
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